Difference between revisions of "Research:Coronavirus vaccine"
(Created page with "== Research == === Spelling variants === ===Synonyms=== * ===Definition/description=== Source: ===Examples=== '''1)''' Source: === Collocations === * ===Keyness=== ===No...") |
(formatting) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Research == | == Research == | ||
=== | === Variants and synonyms === | ||
* COVID-19 vaccine | |||
* SARS-CoV-2 vaccine | |||
* | * | ||
===Definition/description=== | ===Definition/description=== | ||
Source: | Efforts to design a coronavirus vaccine have focused on a variety of approaches including development of inactivated virus, live-attenuated virus, and a variety of subunit vaccines. | ||
<small>Source: https://www.mdpi.com/1999-4915/6/7/2531</small> | |||
All coronavirus vaccine candidates are directed against the Spike protein (S protein), the most immunological component of coronaviruses. | |||
<small>Source: https://www.mdpi.com/2414-6366/4/1/31</small> | |||
===Examples=== | ===Examples=== | ||
''' | <blockquote>The re-emergence of lethal coronaviruses calls for international collaboration to produce '''coronavirus vaccines''', which are still lacking to date. </blockquote><small>Source: https://www.sciencedirect.com/science/article/pii/S1879625716301481?via%3Dihub</small><blockquote>They summarize the challenges of developing a successful, protective '''coronavirus vaccine''', especially for SARS-CoV.</blockquote><small>Source: https://www.futuremedicine.com/doi/10.2217/17460794.3.2.119</small> | ||
=== Collocations === | |||
* novel coronavirus vaccine | |||
* develop coronavirus vaccine | |||
* efficient coronavirus vaccine | |||
* efficacious coronavirus vaccine | |||
* live / killed coronavirus vaccine | |||
* coronavirus vaccine development | |||
* coronavirus vaccine candidate | |||
* | * | ||
===Keyness=== | ===Keyness=== | ||
* coronavirus vaccine: >1000 | |||
* COVID-19 vaccine: >1000 | |||
* SARS-CoV-2 vaccine: >1000 | |||
Latest revision as of 20:09, 7 March 2022
Research
Variants and synonyms
- COVID-19 vaccine
- SARS-CoV-2 vaccine
Definition/description
Efforts to design a coronavirus vaccine have focused on a variety of approaches including development of inactivated virus, live-attenuated virus, and a variety of subunit vaccines.
Source: https://www.mdpi.com/1999-4915/6/7/2531
All coronavirus vaccine candidates are directed against the Spike protein (S protein), the most immunological component of coronaviruses.
Source: https://www.mdpi.com/2414-6366/4/1/31
Examples
The re-emergence of lethal coronaviruses calls for international collaboration to produce coronavirus vaccines, which are still lacking to date.
Source: https://www.sciencedirect.com/science/article/pii/S1879625716301481?via%3Dihub
They summarize the challenges of developing a successful, protective coronavirus vaccine, especially for SARS-CoV.
Source: https://www.futuremedicine.com/doi/10.2217/17460794.3.2.119
Collocations
- novel coronavirus vaccine
- develop coronavirus vaccine
- efficient coronavirus vaccine
- efficacious coronavirus vaccine
- live / killed coronavirus vaccine
- coronavirus vaccine development
- coronavirus vaccine candidate
Keyness
- coronavirus vaccine: >1000
- COVID-19 vaccine: >1000
- SARS-CoV-2 vaccine: >1000